The rating affirmation is based on a number of factors, including Holy Redeemer’s low revenue growth and challenges operating in a competitive Philadelphia market with concentrated payers.
The outlook is stable, reflecting expected maintenance of balance sheet strength to mitigate risks of volume declines in a competitive market.
More articles on healthcare finance:
How CHS, Tenet, UHS, LifePoint and HCA fared in Q4
Artificial Medical Intelligence introduces new coding and reimbursement software: 5 things to know
AG to Minn. hospitals: Refund sexual violence victims
